Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000-2006

International Urology and Nephrology

Volumn 41, Issue 4, 2009, Pages 953-957

  Catal, Ferhat ^a   Bavbek, Nuket ^a,b   Bayrak, Omer ^a   Karabel, Musemma ^a   Karabel, Duran ^a   Odemis, Ender ^a   Uz, Ebru ^a  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^b NONE   (Turkey)

Author keywords

Antibiotic resistance; Children; Empirical treatment; Urinary tract infection

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NITROFURANTOIN; PIPERACILLIN;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HUMAN; INFANT; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NONHUMAN; PRESCHOOL CHILD; PROTEUS MIRABILIS; RETROSPECTIVE STUDY; SCHOOL CHILD; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL; URINALYSIS; URINARY TRACT INFECTION;

ADOLESCENT; AMIKACIN; AMPICILLIN; ANALYSIS OF VARIANCE; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; COHORT STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; GENTAMICINS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TURKEY; URINALYSIS; URINARY TRACT INFECTIONS; URINE;

EID: 77954563825     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-008-9445-5     Document Type: Article

References (21)

1. Elder JS (2000) Urologic disorders in infants and children. In: Behrman RE, Kliegman RM, Jenson HB (eds) Nelson textbook of pediatrics, 16th edn. WB Saunders, Philadelphia, pp 1621-1625
2. Adjei O, Opoku C (2004) Urinary tract infections in African infants. Int J Antimicrob Agents 24:32-34. doi: 10.1016/j.ijantimicag.2004.02.007 (Pubitemid 39208857)
3. Allen UD, MacDonald N et al (1999) Risk factors for resistance to 'first-line' antimicrobials among urinary tract isolates of Escherichia coli in children. CMAJ 160:1436-1440
4. Haller M, Brandis M, Berner R (2004) Antibiotic resistance of urinary tract pathogens and rationale for empirical intravenous therapy. Pediatr Nephrol 19:982-986. doi: 10.1007/s00467-004-1528-7 (Pubitemid 39242779)
5. Ladhani S, Gransden W (2003) Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child 88:444-445. doi: 10.1136/adc.88.5.444 (Pubitemid 36566734)
6. National Committee for Clinical Laboratory Standards (2002) Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement. Approved Standard. M100-S12. NCCLS, Wayne, PA
7. Grunberg RN (1994) Changes in urinary pathogens and their antibiotic sensitivities, 1971-1992. J Antimicrob Chemother 33:1-8. doi: 10.1093/jac/33.1.1
8. Barrett SP, Savage MA, Rebec MP, Guyot A, Andrews N, Shrimpton SB (1999) Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J Antimicrob Chemother 44:359-365. doi: 10.1093/jac/44.3.359 (Pubitemid 29425687)
9. Beunders AJ (1994) Development of antibacterial resistance. The Dutch experience. J Antimicrob Chemother 33:17-22
10. Winstanley TG, Limb DI et al (1997) A 10-year survey of the antimicrobial susceptibility of urinary tract isolates in the UK: the Microbe Base project. J Antimicrob Chemother 40:591-594. doi: 10.1093/jac/40.4.591 (Pubitemid 27480496)
11. Gupta K, Scholes D et al (1999) Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 281:736-738. doi: 10.1001/jama.281.8.736 (Pubitemid 29113455)
12. Weber G, Riesenberg K et al (1997) Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatient clinics and a hospital in Southern Israel, 1991-1995. Eur J Clin Microbiol Infect Dis 16:834-835. doi: 10.1007/BF01700414
13. Prais D, Straussberg R et al (2003) Bacterial susceptibility to oral antibiotics in community acquired urinary tract infection. Arch Dis Child 88:215-218. doi: 10.1136/adc.88. 3.215
14. Carapetis JR, Jaquiery AL et al (2001) Randomized, controlled trial comparing once daily and three times daily gentamicin in children with urinary tract infections. Pediatr Infect Dis J 20:240-246. doi: 10.1097/00006454-20010 3000-00004
15. Bronzwaer SL, Cars O, and participants in the European Antimicrobial Surveillance System et al (2002) A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 8:278-282
16. Patterson JE (2002) Extended spectrum beta-lactamases: a therapeutic dilemma. Pediatr Infect Dis J 21:957-959. doi: 10.1097/00006454-200210000-00014 (Pubitemid 35176158)
17. Bonnet R (2004) Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48:1-14. doi: 10.1128/AAC.48.1.1-14. 2004 (Pubitemid 38040170)
18. Patterson JE, Hardin TC, Kelly CA, Garcia RC, Jorgensen JH (2000) Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol 21:455-458. doi: 10.1086/501787
19. Toltzis P, Dul M et al (2003) Cefepime use in pediatric intensive care unit reduces colonization with resistant bacilli. Pediatr Infect Dis J 22:109-114
20. Swartz MN (1997) Use of antimicrobial agents and drug resistance. N Engl J Med 337:491-492. doi: 10.1056/ NEJM199708143370709
21. Goldmann DA, Weinstein RA et al (1996) Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. Workshop to Prevent, Control the Emergence, Spread of Antimicrobial Resistant Microorganisms in Hospitals. JAMA 275:234-240. doi: 10.1001/jama.275.3.234 (Pubitemid 26028565)